• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雄激素受体表达在前列腺癌放疗根治性治疗中的作用:一项初步研究。

The role of androgen receptor expression in the curative treatment of prostate cancer with radiotherapy: a pilot study.

作者信息

Poelaert Filip, Van Praet Charles, Beerens Anne-Sophie, De Meerleer Gert, Fonteyne Valérie, Ost Piet, Lumen Nicolaas

机构信息

Department of Urology, Ghent University Hospital, De Pintelaan 185, 9000 Gent, Belgium.

Department of Pathology, Ghent University Hospital, De Pintelaan 185, 9000 Gent, Belgium.

出版信息

Biomed Res Int. 2015;2015:812815. doi: 10.1155/2015/812815. Epub 2015 Feb 22.

DOI:10.1155/2015/812815
PMID:25793207
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4352440/
Abstract

The androgen receptor (AR) and its signaling pathway play an important role in the development and progression of prostate cancer (PCa). In the setting of primary treatment of PCa with radiotherapy (RT), where the AR can be expected to be of more importance, studies evaluating the AR expression are lacking. The goal of this research is to evaluate AR protein expression in hormone-naive PCa patients treated by RT and investigate its possible prognostic role. Primary biopsy samples of 18 patients treated with primary RT were analyzed including the corresponding clinical information. AR protein expression of the tumor epithelium (with highest Gleason pattern) and the surrounding stroma was quantified using the Quick score for steroid receptors. The differential expression between epithelium and stroma, respectively, between tumor and normal tissue (ΔTumor - ΔBenign >2 versus ≤ 2), was predictive for clinical progression-free survival in the biopsy samples (P = 0.014). Preliminary results of this research show already a promising role of differential AR expression in predicting clinical relapse after PCa treatment with primary EBRT. Further research is needed to validate these findings. Hopefully this can lead to a better understanding of PCa evolution and eventually lead to better therapy strategies.

摘要

雄激素受体(AR)及其信号通路在前列腺癌(PCa)的发生和发展中起着重要作用。在前列腺癌的放射治疗(RT)初始治疗中,预计AR会发挥更重要的作用,但目前缺乏评估AR表达的研究。本研究的目的是评估接受RT治疗的激素初治前列腺癌患者的AR蛋白表达,并探讨其可能的预后作用。分析了18例接受初次RT治疗患者的原发活检样本,并纳入相应的临床信息。使用类固醇受体快速评分法对肿瘤上皮(最高Gleason分级)和周围基质中的AR蛋白表达进行定量。上皮与基质之间、肿瘤与正常组织之间的差异表达(Δ肿瘤 - Δ良性>2 vs ≤ 2)可预测活检样本中的临床无进展生存期(P = 0.014)。本研究的初步结果已显示AR差异表达在预测初次体外放射治疗(EBRT)后前列腺癌临床复发方面具有潜在作用。需要进一步研究来验证这些发现。希望这能有助于更好地理解前列腺癌的演变,并最终带来更好的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c55/4352440/7b9f79d3bb18/BMRI2015-812815.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c55/4352440/a19643086b9d/BMRI2015-812815.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c55/4352440/f8f5eaa07ce4/BMRI2015-812815.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c55/4352440/7628dc29eba5/BMRI2015-812815.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c55/4352440/0ca7b5899605/BMRI2015-812815.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c55/4352440/7b9f79d3bb18/BMRI2015-812815.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c55/4352440/a19643086b9d/BMRI2015-812815.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c55/4352440/f8f5eaa07ce4/BMRI2015-812815.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c55/4352440/7628dc29eba5/BMRI2015-812815.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c55/4352440/0ca7b5899605/BMRI2015-812815.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c55/4352440/7b9f79d3bb18/BMRI2015-812815.005.jpg

相似文献

1
The role of androgen receptor expression in the curative treatment of prostate cancer with radiotherapy: a pilot study.雄激素受体表达在前列腺癌放疗根治性治疗中的作用:一项初步研究。
Biomed Res Int. 2015;2015:812815. doi: 10.1155/2015/812815. Epub 2015 Feb 22.
2
Androgen action in the prostate gland.雄激素在前列腺中的作用。
Minerva Urol Nefrol. 2012 Mar;64(1):35-49.
3
Androgen Receptor Gene Copy Number and Protein Expression in Treatment-Naïve Prostate Cancer.未经治疗的前列腺癌中雄激素受体基因拷贝数与蛋白表达
Urol Int. 2017;99(2):222-228. doi: 10.1159/000455158. Epub 2017 Jan 5.
4
The long non-coding RNA PCGEM1 is regulated by androgen receptor activity in vivo.长链非编码RNA PCGEM1在体内受雄激素受体活性调控。
Mol Cancer. 2015 Feb 21;14:46. doi: 10.1186/s12943-015-0314-4.
5
Expression of androgen and estrogen signaling components and stem cell markers to predict cancer progression and cancer-specific survival in patients with metastatic prostate cancer.雄激素和雌激素信号成分以及干细胞标志物的表达预测转移性前列腺癌患者的癌症进展和癌症特异性生存。
Clin Cancer Res. 2014 Sep 1;20(17):4625-35. doi: 10.1158/1078-0432.CCR-13-1105. Epub 2014 Jul 1.
6
Differential expression of steroid receptors in prostate tissues before and after radiation therapy for prostatic adenocarcinoma.前列腺腺癌放射治疗前后前列腺组织中类固醇受体的差异表达。
Int J Cancer. 2005 Nov 10;117(3):381-6. doi: 10.1002/ijc.21174.
7
Altered expression of androgen receptor in the malignant epithelium and adjacent stroma is associated with early relapse in prostate cancer.雄激素受体在前列腺癌恶性上皮及相邻基质中的表达改变与早期复发相关。
Cancer Res. 2001 Jan 15;61(2):423-7.
8
Androgen receptor gene amplification and protein expression in recurrent prostate cancer.复发性前列腺癌中雄激素受体基因扩增与蛋白表达
J Urol. 2003 Nov;170(5):1817-21. doi: 10.1097/01.ju.0000091873.09677.f4.
9
Low stroma androgen receptor level in normal and tumor prostate tissue is related to poor outcome in prostate cancer patients.正常和肿瘤前列腺组织中低基质雄激素受体水平与前列腺癌患者的不良预后相关。
Prostate. 2009 Jun 1;69(8):799-809. doi: 10.1002/pros.20927.
10
Role of androgen receptor in prostatic neoplasia versus hyperplasia.雄激素受体在前列腺肿瘤与增生中的作用。
J Cancer Res Ther. 2016 Jan-Mar;12(1):112-6. doi: 10.4103/0973-1482.151429.

引用本文的文献

1
Extract Induces Apoptosis via Generation of Reactive Oxygen Species and Inhibition of Heat Shock Protein 27 and Androgen Receptor in Prostate Cancers.提取物通过产生活性氧以及抑制前列腺癌中的热休克蛋白27和雄激素受体来诱导细胞凋亡。
Int J Mol Sci. 2024 Feb 28;25(5):2799. doi: 10.3390/ijms25052799.
2
The role of androgen receptors in vascular and cell proliferation of the prostate adenocarcinomas.雄激素受体在前列腺腺癌血管和细胞增殖中的作用。
Rom J Morphol Embryol. 2020 Jul-Sep;61(3):803-811. doi: 10.47162/RJME.61.3.18.
3
Fluorine-18 Labeled Fluorofuranylnorprogesterone ([F]FFNP) and Dihydrotestosterone ([F]FDHT) Prepared by "Fluorination on Sep-Pak" Method.

本文引用的文献

1
Focal amplification of the androgen receptor gene in hormone-naive human prostate cancer.雄激素受体基因在激素非依赖型人前列腺癌中的局灶扩增。
Br J Cancer. 2014 Mar 18;110(6):1655-62. doi: 10.1038/bjc.2014.13. Epub 2014 Jan 30.
2
Intensity modulated radiotherapy induces pro-inflammatory and pro-survival responses in prostate cancer patients.调强放疗可诱导前列腺癌患者产生促炎和促生存反应。
Int J Oncol. 2014 Apr;44(4):1073-83. doi: 10.3892/ijo.2014.2260. Epub 2014 Jan 17.
3
EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.
通过“Sep-Pak 氟代法”制备 18F 标记的氟呋喃诺孕酯([F]FFNP)和二氢睾酮([F]FDHT)。
Molecules. 2019 Jun 28;24(13):2389. doi: 10.3390/molecules24132389.
4
GOLPH3 and YB-1 Are Novel Markers Correlating With Poor Prognosis in Prostate Cancer.高尔基体磷蛋白3(GOLPH3)和Y盒结合蛋白1(YB-1)是与前列腺癌预后不良相关的新型标志物。
World J Oncol. 2015 Dec;6(6):473-484. doi: 10.14740/wjon952w. Epub 2015 Dec 31.
5
Refinement of the androgen response element based on ChIP-Seq in androgen-insensitive and androgen-responsive prostate cancer cell lines.基于 ChIP-Seq 在雄激素不敏感和雄激素反应性前列腺癌细胞系中雄激素反应元件的精细化研究。
Sci Rep. 2016 Sep 14;6:32611. doi: 10.1038/srep32611.
EAU 前列腺癌指南。第二部分:晚期、复发性和去势抵抗性前列腺癌的治疗。
Eur Urol. 2014 Feb;65(2):467-79. doi: 10.1016/j.eururo.2013.11.002. Epub 2013 Nov 12.
4
Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade.糖皮质激素受体通过绕过雄激素受体阻断来赋予抗雄激素药物耐药性。
Cell. 2013 Dec 5;155(6):1309-22. doi: 10.1016/j.cell.2013.11.012.
5
EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013.EAU 前列腺癌指南。第 1 部分:筛查、诊断和以治愈为目的的局部治疗——2013 年更新。
Eur Urol. 2014 Jan;65(1):124-37. doi: 10.1016/j.eururo.2013.09.046. Epub 2013 Oct 6.
6
Genes upregulated in prostate cancer reactive stroma promote prostate cancer progression in vivo.前列腺癌反应性基质中上调的基因促进体内前列腺癌的进展。
Clin Cancer Res. 2014 Jan 1;20(1):100-9. doi: 10.1158/1078-0432.CCR-13-1184. Epub 2013 Oct 22.
7
The transcriptional programme of the androgen receptor (AR) in prostate cancer.前列腺癌中雄激素受体(AR)的转录程序。
BJU Int. 2014 Mar;113(3):358-66. doi: 10.1111/bju.12415.
8
Androgen receptor signaling regulates DNA repair in prostate cancers.雄激素受体信号调节前列腺癌中的 DNA 修复。
Cancer Discov. 2013 Nov;3(11):1245-53. doi: 10.1158/2159-8290.CD-13-0172. Epub 2013 Sep 11.
9
Androgen receptor in human prostate cancer-associated fibroblasts promotes prostate cancer epithelial cell growth and invasion.人前列腺癌相关成纤维细胞中的雄激素受体促进前列腺癌细胞上皮生长和侵袭。
Med Oncol. 2013;30(3):674. doi: 10.1007/s12032-013-0674-9. Epub 2013 Aug 8.
10
A road map to comprehensive androgen receptor axis targeting for castration-resistant prostate cancer.雄激素受体轴靶向治疗去势抵抗性前列腺癌的路线图
Cancer Res. 2013 Aug 1;73(15):4599-605. doi: 10.1158/0008-5472.CAN-12-4414. Epub 2013 Jul 25.